澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

NEURIZON THERAPEUTICS LTD

0.081

-0.003-3.57%

成交量：25.64万

成交额：2.10万

市值：5,658.89万

市盈率：-2.74

高：0.084

开：0.082

低：0.081

收：0.084

52周最高：0.185

52周最低：0.076

股本：6.99亿

流通股本：3.51亿

量比：0.39

换手率：0.07%

股息：- -

股息率：- -

每股收益(TTM):-0.030

每股收益(LYR):-0.034

净资产收益率：-147.09%

总资产收益率：-60.21%

市净率：6.83

市盈率(LYR):-2.38

数据加载中...

总览公司新闻资讯公告

NEURIZON THERAPEUTICS LTD 成功在全部重点市场获得Neurizon®注册商标保护

NEURIZON THERAPEUTICS LTD获准进入Healey ALS Platform Trial 试验预计2025年第四季度启动

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NUZ.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"NUZ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NUZ.AU\",,,,,undefined,":{"symbol":"NUZ.AU","market":"AU","secType":"STK","nameCN":"NEURIZON THERAPEUTICS LTD","latestPrice":0.081,"timestamp":1774233913999,"preClose":0.084,"halted":0,"volume":256430,"delay":0,"changeRate":-0.03571428571428575,"nameEN":"NEURIZON THERAPEUTICS LTD","floatShares":351374969,"shares":698628681,"eps":-0.029543,"marketStatus":"交易中","change":-0.003,"latestTime":"03-23 14:27:17 AEDT","open":0.082,"high":0.084,"low":0.081,"amount":20970,"amplitude":0.035714,"askPrice":0.084,"askSize":60332,"bidPrice":0.081,"bidSize":276712,"shortable":3,"etf":0,"ttmEps":-0.029543,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774242000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.084,"openAndCloseTimeList":[[1774220400000,1774242000000]],"volumeRatio":0.38629,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NUZ.AU","preClose":0.084,"auctionPrice":0.082,"auctionVolume":160000,"auctionTime":1774220346677,"referenceTime":1773912604089,"auction":1,"marketStatus":"盘前竞价","timestamp":1774220346677}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NUZ.AU\",,,,,undefined,":{"symbol":"NUZ.AU","floatShares":351374969,"roa":"-60.21%","roe":"-147.09%","lyrEps":-0.034045,"volumeRatio":0.38629,"shares":698628681,"dividePrice":0,"high":0.084,"amplitude":0.035714,"preClose":0.084,"low":0.081,"week52Low":0.076,"pbRate":"6.83","psRate":"9.46","week52High":0.185,"institutionHeld":0,"latestPrice":0.081,"committee":0.641993,"eps":-0.029543,"divideRate":0,"volume":256430,"delay":0,"ttmEps":-0.029543,"open":0.082,"prevYearClose":0.085,"prevWeekClose":0.084,"prevMonthClose":0.092,"prevQuarterClose":0.085,"fiveDayClose":0.08,"twentyDayClose":0.096,"sixtyDayClose":0.085,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NUZ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NUZ.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NUZ.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1104526042","title":"NEURIZON THERAPEUTICS LTD 成功在全部重点市场获得Neurizon®注册商标保护","url":"https://stock-news.laohu8.com/highlight/detail?id=1104526042","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104526042?lang=zh_cn&edition=fundamental","pubTime":"2026-01-20 06:50","pubTimestamp":1768863015,"startTime":"0","endTime":"0","summary":"NEURIZON THERAPEUTICS LTD 宣布，其核心品牌Neurizon®已在全球所有重点市场成功获得注册商标法律保护。这一重要进展标志着公司在知识产权战略布局上取得关键突破，为未来产品全球化商业推广奠定了坚实的法律基础。商标保护的全面落实，不仅有效防范潜在侵权风险，更将显著提升品牌价值与国际市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","NUZ.AU"],"gpt_icon":0},{"id":"1103342926","title":"NEURIZON THERAPEUTICS LTD获准进入Healey ALS Platform Trial 试验预计2025年第四季度启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1103342926","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103342926?lang=zh_cn&edition=fundamental","pubTime":"2025-10-06 14:08","pubTimestamp":1759730897,"startTime":"0","endTime":"0","summary":"NEURIZON THERAPEUTICS LTD获准进入Healey ALS Platform Trial，该试验预计将于2025年第四季度正式启动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","NUZ.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}